Physician profile
Robert Douglas Bostick
NPI 1518916915
$8,261.19
in general payments reported to CMS, 2019-2025
31 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,616 · 2020: $1,703 · 2021: $1,046 · 2022: $200 · 2023: $1,019 · 2024: $723 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Travel and Lodging: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.49 |
| Travel and Lodging | $507.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,564.84 | 2019-2025 | Mako, Salvation, Aequalis Perform |
| Alon Medical Technology | $1,059.22 | 2020 | |
| Encore Medical, LP | $739.55 | 2021 | |
| Depuy Synthes Sales INC. | $367.92 | 2021-2025 | Monovisc |
| Bioventus LLC | $183.70 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Ferring Pharmaceuticals INC. | $183.26 | 2019-2024 | Euflexxa |
| Heron Therapeutics, INC. | $148.10 | 2023 | Zynrelef |
| Vericel Corporation | $140.75 | 2020-2024 | Maci |
| Siemens Medical Solutions USA, INC. | $130.43 | 2020 | |
| Arthrex, INC. | $85.99 | 2019 | |
| Fidia Pharma USA INC. | $78.01 | 2021-2024 | Hymovis, Hyalgan, Triluron |
| Pfizer INC. | $74.32 | 2020-2021 | |
| Virtus Pharmaceuticals LLC | $52.45 | 2024 | Levorphanol Tartrate |
| Ermi LLC | $48.85 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $45.09 | 2021-2024 | Zilretta, Iovera, Exparel |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $30.62 | 2019 | |
| Medacta USA, INC. | $30.00 | 2024 | |
| Horizon Therapeutics Plc | $29.70 | 2019-2022 | |
| Avanos Medical | $29.26 | 2022-2025 | On-Q Pump and Accessories |
| Anika Therapeutics, INC. | $28.18 | 2023 | Revomotion |
| Dynasplint Systems INC. | $26.47 | 2022 | |
| Nalu Medical, INC. | $24.06 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $23.93 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Innovation Technologies INC | $23.33 | 2025 | Irrisept |
| Heraeus Medical, LLC. | $21.08 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.64 | 2022 | |
| Pacira Therapeutics, INC. | $16.21 | 2019 | |
| Advanced Oxygen Therapy INC. | $15.23 | 2024 | Topical Oxygen Chamber For Extremities |
| Vertex Pharmaceuticals Incorporated | $14.56 | 2025 | |
| Smith+Nephew, INC. | $13.70 | 2025 | Pico 14 |
| Kowa Pharmaceuticals America, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bostick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.